12 results
424B5
ARVN
Arvinas Inc
6 Aug 21
Prospectus supplement for primary offering
4:34pm
regulatory activities, disrupt our manufacturing and supply chain or have other adverse effects on our business and operations. We cannot be certain what
8-K
EX-10.1
ARVN
Arvinas Inc
22 Jul 21
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein
7:30am
to the JMC, with each representative having knowledge and expertise in the manufacturing and supply chain, and having sufficient seniority within … review and discussion, a proposed supply chain management plan for the Licensed Products being Manufactured under this Agreement by the existing CMOs
424B5
km8 c3m8vu5i
16 Dec 20
Prospectus supplement for primary offering
4:01pm
424B5
gsrdrtvs97xgaq8
14 Dec 20
Prospectus supplement for primary offering
4:48pm
S-3ASR
k0e220tq2la7n4izz50
14 Dec 20
Automatic shelf registration
4:02pm
10-K
puphz
26 Mar 19
Annual report
4:31pm
DRS/A
53n7j7nxc64
2 Aug 18
Draft registration statement (amended)
12:00am
DRS
f35vc4 ebf
22 Jun 18
Draft registration statement
12:00am
- Prev
- 1
- Next